Status:
COMPLETED
The Influence of the 34C>T Variant in the AMPD1 Gene Ischemic Tolerance
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
ZonMw: The Netherlands Organisation for Health Research and Development
Conditions:
AMPD
Ischemic Tolerance
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
Previous epidemiological studies have shown that in cardiovascular patients, the 34C\>T variant in the gene encoding for the enzyme Adenosine Mono Phosphate Deaminase (AMPD1) is associated with prolon...
Eligibility Criteria
Inclusion
- male
- 18-40 years
- healthy
- AMPD1 34C\>T variant (heterozygous) or matched control
Exclusion
- cardiovascular / pulmonary disease
- diabetes / hypertension
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00319059
Start Date
March 1 2006
End Date
April 1 2006
Last Update
April 22 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.